E&Y Responds to Medicare Controversy | AccountingWEB

E&Y Responds to Medicare Controversy

E&Y has produced its own Medicare document, Prescription for Change," which outlines the potential outcomes of current Mediare plans being bandied about, and offers its own solutions to an issue which will affect 1 in 3 Americans within the next two decades.

The E&Y document:

· Examines the drivers that will create the Medicare benefit, regardless of the current political obstacles
· Provides a basic sketch of what the new benefit could look like
· Explains the profound impact a prescription drug benefit will have on stakeholders
· Addresses the questions:

  • Should the benefit be universal, subsidized, or directed to low-income individuals?
  • What role should the federal and state governments play?
  • What role should private industry play?
  • How can consumers be guaranteed a choice while costs are controlled?
  • How will consumers, hospitals, pharmaceutical companies, and other stakeholders be affected?

In addition to the document, E&Y plans to hold a live online webcast Octoboer 25 at which members of the firm will discuss new health care proposals that may affect your business. You can register to attend the free webcast.

Wait, there's more!
There's always more at AccountingWEB. We're an active community of financial professionals and journalists who strive to bring you valuable content every day. If you'd like, let us know your interests and we'll send you a few articles every week either in taxation, practice excellence, or just our most popular stories from that week. It's free to sign up and to be a part of our community.
Premium content is currently locked

Editor's Choice

WHAT KIND OF FIRM ARE YOU?
As part of our continued effort to provide valuable resources and insight to our subscribers, we're conducting this brief survey to learn more about your personal experiences in the accounting profession. We will be giving away five $50 Amazon gift cards, and a $250 Amazon gift card to one lucky participant.
This is strictly for internal use and data will not be sold
or shared with any third parties.